- Advanced Biomarkers and Imaging for Heart Disease. (Malik-PI), NIH/NHLBI, R01 HL128801- NIH National Heart, Lung and Blood Institute
- Electroacupuncture and Autonomic Regulation. (Guo and Malik-MPI), NIH/NCCIH, R01AT009247 – National Center for Complementary and Integrative Health
- Chelation Therapy for Heart Disease. (Malik-Site PI), UH3AT009149 – National Center for Complementary and Integrative Health
- Studying the Neural Mechanisms of Acupuncture on Cardiovascular Function. (Guo, Xu, Malik) – UCI Brain, UCI Office of Research
- Neuroimmune mechanisms underlying electroacupuncture effect on vascular function. (NIH/NCCIH)
- Neural substrates of electroacupuncture in cardiovascular control. (Adolph Coors Foundation)
- Integrative Cardiometabolic Care Approach compaRative Effectiveness (ICARE Study): Evaluating subclinical and clinical markers of disease in cardiometabolic syndrome through integrative cardiovascular care approaches.
Publications
- Role of Opioid Receptors in Modulation of P2X Receptor-Mediated Cardiac Sympathoexcitatory Reflex Response. Fu L, Tjen-A-Looi S, Barvarz S, Guo Z, Malik S
- Adenosine Receptor A 2a, but Not A 1 in the rVLM Participates Along With Opioids in Acupuncture-Mediated Inhibition of Excitatory Cardiovascular Reflexes. Malik S, Samaniego T, Guo Z
- Coronary Artery Calcium Score for Long-term Risk Classification in Individuals with Type 2 Diabetes and Metabolic Syndrome for the Multi-Ethnic Study of Atherosclerosis. Malik S, Zhao Y, Budoff M, Nasir K, Blumenthal RS, Bertoni AG, Wong ND. JAMA Cardiol. 2017 Dec 1;2(12):1332-1340
- Reducing women’s cardiovascular disease risk profile. Kurth J, Malik S. Women’s Health. 2015 Jun; 11(3):385-97.
- The Effect of Morbid Obesity on In-Hospital Mortality and Coronary Revascularization Outcomes After Myocardial Infarction in the United States. Dhoot J, Erande A, Amin A, Patel P, Tariq S, Malik S. Am J Cardiol. 2013 Apr 15;111(8):1104-10.
- The Sirtulin System: The Holy Grail of Resveratrol? Mohar D and Malik S. J Clin Exp Cardiolog. 2012 Nov;3(11).
- Low HDL cholesterol is associated with increased atherogenic lipoproteins and insulin resistance in women classified with metabolic syndrome. Fernandez ML, Jones JJ, Ackerman D, Barona J, Calle M, Comperatore MV, Kim JE, Andersen C, Leite JO, Volek JS, McIntosh M, Kalynych C, Najm W, Lerman RH. Nutr Res Pract. 2010 Dec;4(6):492-8. Epub 2010 Dec 28.
